Literature DB >> 31612474

Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients.

Young Ae Kim1, Hee Young Ju1,2,3, Hyeon Jin Park3, Na Young Lee1, Hyun Jeong Lee1, Hyewon Lee4, Haryeom Ghang5.   

Abstract

This study used Korean national data to investigate the relationship between treatment patterns and outcomes in Korean adolescent and young-adult (AYA) acute lymphoblastic leukaemia (ALL) patients. Chemotherapy incorporating L-asparaginase was considered paediatric-inspired (PI), as opposed to adult protocols. In total, 65·3% of patients received PI therapy. Five-year overall survival (OS) of PI-treated patients outperformed adult protocols (63·1% vs. 40·4%; P < 0·0001); this trend was maintained within various age subgroups. Younger age, L-asparaginase therapy, and radiotherapy corresponded with superior OS by multivariable analysis. OS tends to improve with PI protocols that include L-asparaginase in AYA ALL, suggesting that therapy protocol is critical in the treatment performance of this group.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  Treatment outcome; acute lymphoblastic leukaemia; adolescents; asparaginase; young adults

Year:  2019        PMID: 31612474     DOI: 10.1111/bjh.16242

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  1 in total

Review 1.  Optimal therapy for adolescents and young adults with acute lymphoblastic leukemia-current perspectives.

Authors:  Jae Wook Lee
Journal:  Blood Res       Date:  2020-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.